Robust and cost-effective CRISPR/Cas9 gene editing of primary tumor B cells in Eµ-TCL1 model of chronic lymphocytic leukemia.

ABSTRACT:

SUBMITTER: Del Prete R 

PROVIDER: S-EPMC11327113 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature